Correlative Biomarker Analyses for Optimal Therapeutic Dose Determination of ABBV-383, a B-cell Maturation Antigen (BCMA) X CD3 Bispecific Antibody, in Patients with Relapsed/refractory Multiple Myeloma (RRMM).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要